Industry must acknowledge the pressure payers are under and act responsibly: not only innovating, but cooperating on access, patient pathways, education, and long-term sustainability
Background technique [0002] Diabetes (diabetes) is a sugar, protein, A series of metabolic disorder syndromes such as fat, water and electrolytes are clinically characterized by hyperglycemia
What is Neurobion Injection composed of
Manufacturers have introduced cash-pay programs that lower the price of the branded product directly, which removes much of the savings that made compounding attractive
Robust improvement in glycaemic control (HbA1c) in people with type 2 diabetes, with dose-dependent reductions observed in clinical trials
doi: 10.1007/s13300-020-00792-3 13